Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3275721 | Médecine des Maladies Métaboliques | 2011 | 6 Pages |
Abstract
Although statins are widely used in cardiovascular prevention and dyslipidemia treatment, diet remains highly recommended due to several arguments in high risk patients making dietary mistakes. Indeed, dietary measures lead to an additional decrease in LDL cholesterol, which is still a major risk factor in cardiovascular diseases. They may provide a cardiovascular benefit beyond LDL cholesterol variation. The range of risk reduction can be significant and is certainly additional. Diet is crucial to control some dyslipidemia, more specifically dysbetalipoproteinemia and hyperchylomicronemia. It offers a good risk-benefit balance due to its lack of risk, and its implementation can lead to additional improvements of health behaviour. Additionally, being not expensive, it can also reduce public health expenses. Moreover, dietary intervention involves not only lipid measurements, but may reduce, beyond cardiovascular prevention, the risk of cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
P. Moulin, S. Charrière, E. Bruckert,